Literature DB >> 14648142

Headaches with (ipsilateral) autonomic symptoms.

Arne May1.   

Abstract

Primary short-lasting headaches broadly divide themselves into those associated with autonomic symptoms, so called trigemino-autonomic cephalgias (TACs), and those with little autonomic syndromes. The trigeminoautonomic cephalgias include cluster headache and paroxysmal hemicranias, in which head pain and cranial autonomic symptoms are prominent. The most striking feature of cluster headache is the circadian and circannual periodicity of the attacks. Inheritance may play a role in some families. The attacks are of extreme intensity, of short duration, occur unilaterally, and are accompanied by symptoms of autonomic dysfunction. Medical treatment includes both acute therapy aimed at aborting individual attacks and prophylactic therapy aimed at preventing recurrent attacks during the cluster period. Some types of trigemino-autonomic headaches, such as paroxysmal hemicrania and hemicrania continua have, unlike cluster headaches, a very robust response to indomethacin, leading to a consideration of indomethacin-sensitive headaches.

Entities:  

Mesh:

Year:  2003        PMID: 14648142     DOI: 10.1007/s00415-003-0241-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  3 in total

Review 1.  Update on the diagnosis and management of trigemino-autonomic headaches.

Authors:  Arne May
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

2.  [Treatment and prophylaxis for cluster headaches and other trigeminal autonomic headaches. Revised recommendations of the German Migraine and Headache Society].

Authors:  A May; S Evers; A Straube; V Pfaffenrath; H C Diener
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

3.  Neuromodulation of chronic headaches: position statement from the European Headache Federation.

Authors:  Paolo Martelletti; Rigmor H Jensen; Andrea Antal; Roberto Arcioni; Filippo Brighina; Marina de Tommaso; Angelo Franzini; Denys Fontaine; Max Heiland; Tim P Jürgens; Massimo Leone; Delphine Magis; Koen Paemeleire; Stefano Palmisani; Walter Paulus; Arne May
Journal:  J Headache Pain       Date:  2013-10-21       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.